The role of core antigen detection in management of hepatitis C: A critical review

Journal of Clinical Virology

Volumn 32, Issue 2, 2005, Pages 92-101

  Seme, Katja ^a   Poljak, Mario ^a   Babič, Dunja Z ^a   Močilnik, Tina ^a   Vince, Adriana ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Croatia   (Croatia)

Author keywords

Core antigen; HCV; Hepatitis C; Hepatitis C virus; Review

Indexed keywords

NUCLEIC ACID; PEGINTERFERON; RIBAVIRIN; VIRUS PROTEIN; VIRUS RNA;

ANTIBODY SCREENING; ANTIGEN DETECTION; BLOOD TRANSFUSION; CHEMOLUMINESCENCE; COMPARATIVE STUDY; CORRELATION ANALYSIS; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HUMAN; IMMUNOASSAY; LIPID METABOLISM; MEDICAL LITERATURE; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVIEW; SCREENING; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS; VIRAL CORE PROTEINS;

EID: 11844303429     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.10.005     Document Type: Review

References (72)

1. S. Agha, Y. Tanaka, N. Saudy, F. Kurbanov, M. Abo-Zeid, and M. El-Malky Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan J Med Virol 73 2004 216 222
2. H.J. Alter Hepatology highlights Hepatology 35 2002 741 742
3. K. Aoyagi, C. Ohue, K. Iida, T. Kimura, E. Tanaka, and K. Kiyosawa Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen J Clin Microbiol 37 1999 1802 1808
4. M. Bouvier-Alias, K. Patel, H. Dahari, S. Beaucourt, P. Larderie, and L. Blatt Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication Hepatology 36 2002 211 218
5. E. Brojer, G. Liszewski, A. Niznik, A. Rosiek, M. Letowska, and J.E. Peterson Detection of HCV core antigen in HCV RNA positive, anti-HCV negative blood donations from Polish blood donors Transfusion 41 2001 304
6. M. Buti, C. Mendez, M. Schaper, S. Sauleda, A. Valdes, and F. Rodriguez-Frias Hepatitis C virus core antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin J Hepatol 40 2004 527 532
7. L. Cagnon, P. Wagaman, R. Bartenschlager, T. Pietschmann, T. Gao, and N.M. Kneteman Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems J Virol Methods 118 2004 23 31
8. H. Cano, M.J. Candela, M.L. Lozano, and V. Vicente Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors Transfus Med 13 2003 259 266
9. A. Cividini, A. Cerino, A. Muzzi, M. Furione, C. Rebucci, and L. Segagni Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C J Clin Microbiol 41 2003 2144 2146
10. A.M. Courouce, N. Le Marrec, F. Bouchardeau, A. Razer, M. Maniez, and S. Laperche Efficacy of HCV core antigen detection during the preseroconversion period Transfusion 40 2000 1198 1202
11. R.C. Dickson, M. Mizokami, E. Orito, K.P. Qian, and J.Y. Lau Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C - clinical and virologic implications Transplantation 68 1999 1512 1516
12. J. Diment, and M. Calmann Alternatives to nucleic acid testing in the blood transfusion service Lancet 360 2002 1518 1519
13. B.C. Dow, H. Munro, I. Buchanan, K. Ferguson, F. Davidson, and C. Lycett Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening Vox Sang 86 2004 15 20
14. X. Forns, and J. Bukh The molecular biology of hepatitis C virus: genotypes and quasispecies Clin Liver Dis 3 1999 693 716
15. P.R. Grant, C.M. Sims, and R.S. Tedder Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion Transfusion 42 2002 1032 1036
16. I. Haas, E. Stelzl, J. Haas, E. Marth, and H.H. Kessler Evaluation of total hepatitis C virus core antigen quantification J Lab Med 28 2004 97 100
17. R.G. Hope, and J. McLauchlan Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein J Gen Virol 81 2000 1913 1925
18. G. Icardi, F. Ansaldi, B.M. Bruzzone, P. Durando, S. Lee, and C. de Luigi Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen J Clin Microbiol 39 2001 3110 3114
19. G. Icardi, B. Bruzzone, F. Gota, F. Torre, E. Giannini, and L. Massone A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? Ann Ig 15 2003 863 870
20. T. Kashiwakuma, A. Hasegawa, T. Kajita, A. Takata, H. Mori, and Y. Ohta Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA) J Immunol Methods 190 1996 79 89
21. N. Kato Molecular virology of hepatitis C virus Acta Med Okayama 55 2001 133 159
22. S. Kawai, O. Yokosuka, F. Imazeki, H. Saisho, and C. Mizuno Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level J Med Virol 68 2002 343 351
23. H.H. Kessler, A.M. Clarici, E. Stelzl, G. Muhlbauer, E. Daghofer, and B.I. Santner Fully automated detection of hepatitis C virus RNA in serum and whole-blood samples Clin Diagn Lab Immunol 9 2002 1385 1388
24. M. Kobayashi, E. Tanaka, A. Matsumoto, K. Yoshizawa, H. Imai, and T. Sodeyama Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C J Gastroenterol 33 1998 508 511
25. F. Komatsu, and K. Takasaki Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients Liver 19 1999 375 380
26. M. Krajden, R. Shivji, K. Gunadasa, A. Mak, G. McNabb, and M. Friesenhahn Evaluation of the core antigen assay as a second-line supplemental test fordiagnosis of active hepatitis C virus infection J Clin Microbiol 42 2004 4054 4059
27. J.B. Kurtz, E. Boxall, N. Qusir, J. Shirley, D. Coleman, and C. Chandler The diagnostic significance of an assay for 'total' hepatitis C core antigen J Virol Methods 96 2001 127 132
28. L.M. Lagging, C.E. Garcia, J. Westin, R. Wejstal, G. Norkrans, and A.P. Dhillon Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time J Clin Microbiol 40 2002 4224 4229
29. M.M. Lai, and C.F. Ware Hepatitis C virus core protein: possible roles in viral pathogenesis Curr Top Microbiol Immunol 242 2000 117 134
30. S. Laperche, N. Le Marrec, N. Simon, F. Bouchardeau, C. Defer, and M. Maniez-Montreuil A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection Transfusion 43 2003 958 962
31. S.R. Lee, J. Peterson, P. Niven, C. Bahl, E. Page, and R. DeLeys Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations Vox Sang 80 2001 19 23
32. M. Letowska, E. Brojer, M. Mikulska, A. Gronowska, and A. Rosiek Hepatitis C core antigen in Polish blood donors Transfusion 44 2004 1067 1071
33. J. Lorenzo, A. Castro, A. Aguilera, E. Prieto, S. Lopez-Calvo, and B. Regueiro Total HCV core antigen assay A new marker of HCV viremia and its application during treatment of chronic hepatitis C J Virol Methods 120 2004 173 177
34. Fontevraud Study Group F. Lunel, P. Veillon, I. Fouchard-Hubert, V. Loustaud-Ratti, A. Abergel, and C. Silvain Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen J Hepatol 39 2003 826 833
35. P. Maillard, K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, and P. Gounon Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients J Virol 75 2001 8240 8250
36. M. Maynard, P. Pradat, P. Berthillon, G. Picchio, N. Voirin, and M. Martinot Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy J Viral Hepat 10 2003 318 323
37. J. McLauchlan, M.K. Lemberg, G. Hope, and B. Martoglio Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets EMBO J 21 2002 3980 3988
38. J. McLauchlan Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes J Viral Hepat 7 2000 2 14
39. M.U. Mondelli Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts? J Hepatol 40 2004 536 538
40. T. Moriya, F. Sasaki, J. Tanaka, M.A. Mizui, T. Nakanishi, and K. Takahashi Comparison of HCV core antigen activity by ELISA and amount of HCV RNA by branched DNA assay Int Hepatol Commun 2 1994 175 177
41. A.S. Muerhoff, L. Jiang, D.O. Shah, R.A. Gutierrez, J. Patel, and C. Garolis Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay Transfusion 42 2002 349 356
42. M. Nakamuta, N. Shimohashi, S. Tada, N. Kinukawa, M. Enjoji, and K. Uchimura Serum levels of HCV RNA and core protein before and after incubation at 37°C for 24 h Hepatol Res 19 2001 254 262
43. National Institutes of Health National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C, June 10-12 2002 Hepatology 36 Suppl 1 2002 S3 S20
44. D.M. Netski, X.H. Wang, S.H. Mehta, K. Nelson, D. Celentano, and S. Thongsawat Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in Thai injection drug users J Clin Microbiol 42 2004 1631 1636
45. C.M. Nubling, G. Unger, M. Chudy, S. Raia, and J. Lower Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase Transfusion 42 2002 1037 1045
46. E. Orito, M. Mizokami, T. Tanaka, J.Y. Lau, K. Suzuki, and M. Yamauchi Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes Gut 39 1996 876 880
47. J.M. Pawlotsky Use and interpretation of virological tests for hepatitis C Hepatology 36 Suppl 1 2002 S65 S73
48. J.M. Pawlotsky Use and interpretation of hepatitis C virus diagnostic assays Clin Liver Dis 7 2003 127 137
49. J.M. Pawlotsky Clinical virology of hepatitis C P. Marcellin Management of patients with viral hepatitis 2004 APMAHV Paris 21 34
50. F. Penin, J. Dubuisson, F.A. Rey, D. Moradpour, and J.M. Pawlotsky Structural biology of hepatitis C virus Hepatology 39 2004 5 19
51. J. Peterson, G. Green, K. Iida, B. Caldwell, P. Kerrison, and S. Bernich Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection Vox Sang 78 2000 80 85
52. P.L. Piccoli, M. Franchini, G. Gandini, O. Antonello, D. Olzer, and A. Turrini HCV core antigen assay Transfusion 41 2001 1172
53. P. Pradat, M. Maynard, M. Buti, P. Berthillon, G. Picchio, and H.L. Tillmann The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment J Med Virol 73 2004 392 396
54. C. Rebucci, A. Cerino, A. Cividini, L. Timo, M. Furione, and M.U. Mondelli Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay J Clin Microbiol 41 2003 3881 3884
55. R. Saito, H. Yokota, E. Takahashi, F. Mashige, A. Yoneyama, and K. Nakahara Performance of an automated system for quantitation of hepatitis C virus core antigen J Virol Methods 112 2003 93 97
56. C. Sanz, D. Tassies, J. Costa, C. Freire, and A. Pereira The first case of HCV infection detected before seroconversion in blood donors tested by HCV core antigen ELISA Transfusion 42 2002 505 506
57. C.G. Schuttler, C. Thomas, T. Discher, G. Friese, J. Lohmeyer, and R. Schuster Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera J Clin Microbiol 42 2004 1977 1981
58. D.O. Shah, C.D. Chang, L.X. Jiang, K.Y. Cheng, A.S. Muerhoff, and R.A. Gutierrez Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer Transfusion 43 2003 1067 1074
59. P. Simmonds, J. Kurtz, and R.S. Tedder The UK blood transfusion service: over a (patent) barrel? Lancet 359 2002 1713 1714
60. P. Simmonds Viral heterogeneity of the hepatitis C virus J Hepatol 31 1999 54 60
61. R. Soffredini, M.G. Rumi, M.L. Parravicini, G. Ronchi, E. Del Ninno, and A. Russo Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy Am J Gastroenterol 99 2004 1738 1743
62. K. Takahashi, S. Kishimoto, H. Yoshizawa, H. Okamoto, A. Yoshikawa, and S. Mishiro p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts Virology 191 1992 431 434
63. K. Takahashi, H. Okamoto, S. Kishimoto, E. Munekata, K. Tachibana, and Y. Akahane Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts J Gen Virol 73 1992 667 672
64. E. Tanaka, K. Kiyosawa, A. Matsumoto, T. Kashiwakuma, A. Hasegawa, and H. Mori Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa Hepatology 23 1996 1330 1333
65. E. Tanaka, C. Ohue, K. Aoyagi, K. Yamaguchi, S. Yagi, and K. Kiyosawa Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA Hepatology 32 2000 388 393
66. T. Tanaka, J.Y. Lau, M. Mizokami, E. Orito, E. Tanaka, and K. Kiyosawa Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia J Hepatol 23 1995 742 745
67. Y. Tanaka, K. Takagi, T. Fujihara, K. Kitsugi, K. Fujiwara, and K. Hiramatsu High stability of enzyme immunoassay for hepatitis C virus core antigen - evaluation before and after incubation at room temperature Hepatol Res 26 2003 261 267
68. M. Tsutsumi, S. Urashima, A. Takada, T. Date, and Y. Tanaka Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis Hepatology 19 1994 265 272
69. P. Valcavi, M.C. Medici, F. Casula, M.C. Arcangeletti, F. De Conto, and F. Pinardi Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals J Med Virol 73 2004 397 403
70. P. Veillon, C. Payan, G. Picchio, M. Maniez-Montreuil, P. Guntz, and F. Lunel Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and Amplicor Monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy J Clin Microbiol 41 2003 3212 3220
71. A. Widell, V. Molnegren, F. Pieksma, M. Calmann, J. Peterson, and S.R. Lee Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase Transfus Med 12 2002 107 113
72. A.R. Zanetti, L. Romano, M. Brunetto, M. Colombo, G. Bellati, and C. Tackney Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy J Med Virol 70 2003 27 30